Meeting the transfusion needs of a patient with anti-En requires an international effort.

Immunohematology

4American Rare Donor Program, American Red Cross, Philadelphia, PA, US.

Published: April 2024

This extraordinary case showcases the identification of a rare anti-En specificity that was assisted by DNA-based red blood cell antigen typing and collaboration between the hospital blood bank in the United States, the home blood center in Qatar, the blood center Immunohematology Reference Laboratory, as well as the American Rare Donor Program (ARDP) and the International Society for Blood Transfusion (ISBT) International Rare Donor Panel. En is a high-prevalence antigen, and blood samples from over 200 individuals of the extended family in Qatar were crossmatched against the patient's plasma with one compatible En(a-) individual identified. The ISBT International Rare Donor Panel identified an additional donor in Canada, resulting in a total of two En(a-) individuals available to donate blood for the patient.

Download full-text PDF

Source
http://dx.doi.org/10.2478/immunohematology-2024-003DOI Listing

Publication Analysis

Top Keywords

rare donor
12
blood center
8
isbt international
8
international rare
8
donor panel
8
blood
7
meeting transfusion
4
transfusion patient
4
patient anti-en
4
anti-en requires
4

Similar Publications

Background: Despite advancements in prosthetic designs and surgical techniques, patellar dislocation remains a rare but significant complication following total knee arthroplasty, with an incidence ranging between 0.15% and 0.5%.

View Article and Find Full Text PDF

Background: The transfer of mitochondrial DNA into the nuclear genomes of eukaryotes (Numts) has been linked to lifespan in non-human species and recently demonstrated to occur in rare instances from one human generation to the next.

Method: Here we investigated numtogenesis dynamics in humans in two ways. First, we quantified Numts in 1,187 post-mortem brain and blood samples from different individuals.

View Article and Find Full Text PDF

Background: Numerous studies have identified AD-associated molecular and cellular changes to the cortex using single nucleus RNA sequencing (snRNA-seq) and, to a lesser extent, single nucleus ATAC-seq (snATAC-seq), applied to millions of cells across hundreds of donors. It has proven challenging, however, to determine whether changes are consistent because of differences in cohort selection, reported clinical metadata, data pre-processing, cellular taxonomy construction/mapping, and analytical strategies across studies.

Method: We uniformly re-processed 10 publicly available datasets (Table 1) that had applied snRNA-seq to 4.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Ohio State University College of Medicine, Neurobiology of Aging & Resilience Center, Columbus, OH, USA.

Background: The cerebrovasculature is an essential component of brain homeostasis. Cerebrovascular disorders are associated with an increased risk for neurodegenerative diseases, including Alzheimer's disease (AD). However, the mechanisms by which cerebrovascular dysfunction contributes to neurodegeneration are poorly understood.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

University of Washington, Seattle, WA, USA.

Background: The BRAIN Initiative has stimulated development of novel single cell and spatial molecular approaches to understand human brain structure and function. However, traditional methods for human brain specimen collection, including retrospective archival tissues, have not been optimized for these latest methods. A modernized approach that optimizes tissue quality, anatomical precision, and comprehensive, quantitative neuropathological assessments is needed to maximize the impact of the tremendous investment and remarkable technological advances in human neuroscience research.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!